Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-17-024393
Filing Date
2017-06-07
Accepted
2017-06-07 18:01:37
Documents
1
Period of Report
2017-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4168
  Complete submission text file 0001140361-17-024393.txt   5693
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Issuer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O SANGAMO BIOSCIENCES, INC. 501 CANAL BLVD SUITE A-100 RICHMOND CA 94804
Business Address
Mento Steven J (Reporting) CIK: 0001324466 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30171 | Film No.: 17898224